JP2015522036A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522036A5
JP2015522036A5 JP2015520627A JP2015520627A JP2015522036A5 JP 2015522036 A5 JP2015522036 A5 JP 2015522036A5 JP 2015520627 A JP2015520627 A JP 2015520627A JP 2015520627 A JP2015520627 A JP 2015520627A JP 2015522036 A5 JP2015522036 A5 JP 2015522036A5
Authority
JP
Japan
Prior art keywords
alkyl
halogen
cycloalkyl
compound according
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522036A (ja
JP6109934B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048950 external-priority patent/WO2014008197A1/en
Publication of JP2015522036A publication Critical patent/JP2015522036A/ja
Publication of JP2015522036A5 publication Critical patent/JP2015522036A5/ja
Application granted granted Critical
Publication of JP6109934B2 publication Critical patent/JP6109934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520627A 2012-07-03 2013-07-01 脂質合成の複素環モジュレーター Active JP6109934B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261667894P 2012-07-03 2012-07-03
US61/667,894 2012-07-03
US201261698511P 2012-09-07 2012-09-07
US61/698,511 2012-09-07
US201261699819P 2012-09-11 2012-09-11
US61/699,819 2012-09-11
US201361785933P 2013-03-14 2013-03-14
US61/785,933 2013-03-14
PCT/US2013/048950 WO2014008197A1 (en) 2012-07-03 2013-07-01 Heterocyclic modulators of lipid synthesis

Publications (3)

Publication Number Publication Date
JP2015522036A JP2015522036A (ja) 2015-08-03
JP2015522036A5 true JP2015522036A5 (enExample) 2016-08-18
JP6109934B2 JP6109934B2 (ja) 2017-04-05

Family

ID=48790663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520627A Active JP6109934B2 (ja) 2012-07-03 2013-07-01 脂質合成の複素環モジュレーター

Country Status (17)

Country Link
US (3) US9428502B2 (enExample)
EP (1) EP2870150B1 (enExample)
JP (1) JP6109934B2 (enExample)
KR (1) KR102071095B1 (enExample)
CN (1) CN104507928B (enExample)
AU (2) AU2013286894B2 (enExample)
BR (1) BR112015000106B1 (enExample)
CA (1) CA2877999C (enExample)
ES (1) ES2738823T3 (enExample)
IL (1) IL236407A (enExample)
IN (1) IN2015DN00137A (enExample)
MX (1) MX364815B (enExample)
NZ (2) NZ703162A (enExample)
PL (1) PL2870150T3 (enExample)
SG (1) SG11201500024YA (enExample)
WO (1) WO2014008197A1 (enExample)
ZA (1) ZA201409477B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871790B2 (en) * 2011-03-08 2014-10-28 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US20170119786A1 (en) 2011-03-08 2017-05-04 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US9624173B2 (en) * 2011-03-08 2017-04-18 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
JP6109934B2 (ja) 2012-07-03 2017-04-05 3−ブイ・バイオサイエンシーズ・インコーポレイテッド3−V Biosciences,Inc. 脂質合成の複素環モジュレーター
KR20160100329A (ko) * 2013-12-20 2016-08-23 3-브이 바이오사이언시스, 인코포레이티드 지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
CA2935767C (en) * 2014-01-07 2023-01-31 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
ES2833454T3 (es) * 2014-08-15 2021-06-15 Sagimet Biosciences Inc Inhibidor de la ácido graso sintasa para su uso en el tratamiento de un cáncer farmacorresistente
WO2016028971A1 (en) * 2014-08-21 2016-02-25 Bristol-Myers Squibb Company Tied-back benzamide derivatives as potent rock inhibitors
JP6861154B2 (ja) 2014-12-03 2021-04-21 ヤンセン ファーマシューティカ エヌ.ベー. 放射標識されたmGluR2 PETリガンド
CN107428728A (zh) * 2015-03-19 2017-12-01 3-V生物科学股份有限公司 脂质合成的杂环调节剂
JP2018083758A (ja) * 2015-03-25 2018-05-31 旭硝子株式会社 ピラゾール誘導体の製造方法
WO2016205633A1 (en) 2015-06-18 2016-12-22 Cephalon, Inc. 1, 4-substituted piperidine derivatives
MX379846B (es) 2015-06-18 2025-03-11 89Bio Ltd Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
LT3389727T (lt) 2015-12-18 2020-10-12 Janssen Pharmaceutica Nv Radioaktyviai pažymėti mglur2/3 pet ligandai
JP6929285B2 (ja) 2015-12-18 2021-09-01 ヤンセン ファーマシューティカ エヌ.ベー. 放射性標識mGluR2/3PETリガンド
TWI726968B (zh) 2016-01-07 2021-05-11 開曼群島商Cs醫藥技術公司 Egfr酪胺酸激酶之臨床重要突變體之選擇性抑制劑
WO2017119732A1 (en) 2016-01-08 2017-07-13 Samsung Electronics Co., Ltd. Electronic device and operating method thereof
EP3426772A4 (en) 2016-03-09 2019-08-28 Beijing Percans Oncology Co. Ltd. TUMOR CELLSUSPENSION CULTURES AND RELATED METHODS
JP7668509B2 (ja) * 2016-11-11 2025-04-25 サギメット バイオサイエンシーズ インコーポレイテッド 脂質合成の複素環式モジュレーター
US20220340556A1 (en) * 2016-11-11 2022-10-27 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis
CN107954852A (zh) * 2017-11-30 2018-04-24 贝利化学(张家港)有限公司 2,5-二卤代苯甲酸的制备方法
CN113227100B (zh) 2018-12-26 2023-05-05 詹森药业有限公司 噻吩并吡啶酮化合物
CN111592495A (zh) * 2020-07-06 2020-08-28 上海启讯医药科技有限公司 一种2-正丁基-4-氯-5甲酰基咪唑的制备方法
CN114988975A (zh) * 2022-06-28 2022-09-02 江苏科技大学 一种基于有机染料催化的β-三氟甲基烯胺化合物的制备方法
CN116482278B (zh) * 2023-05-06 2024-02-09 广州清瑞生物科技有限责任公司 一种用于检测阿昔洛韦的对照品的制备方法
CN119080742A (zh) * 2023-06-05 2024-12-06 甘莱制药有限公司 脂质合成的杂环调节剂的工业化制备
WO2025086054A1 (zh) * 2023-10-23 2025-05-01 歌礼生物科技(杭州)有限公司 一种包含苯甲腈衍生物的药物组合物
WO2025120168A1 (en) 2023-12-07 2025-06-12 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (Inrae) Sulfonamide derivatives and use thereof in the treatment of cryptosporidium infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006011363D1 (de) 2005-12-01 2010-02-04 Hoffmann La Roche Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
CA2662337A1 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
WO2008059214A1 (en) * 2006-11-13 2008-05-22 Astrazeneca Ab Bisamlde derivatives and use thereof as fatty acid synthase inhibitors
WO2008075077A1 (en) * 2006-12-21 2008-06-26 Astrazeneca Ab Piperidine derivatives for the treatment of obesity
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
TW200833663A (en) * 2006-12-21 2008-08-16 Astrazeneca Ab Therapeutic agents
EP2683244B1 (en) 2011-03-08 2017-02-01 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US20170119786A1 (en) * 2011-03-08 2017-05-04 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US8871790B2 (en) * 2011-03-08 2014-10-28 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US9624173B2 (en) * 2011-03-08 2017-04-18 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
JP6109934B2 (ja) * 2012-07-03 2017-04-05 3−ブイ・バイオサイエンシーズ・インコーポレイテッド3−V Biosciences,Inc. 脂質合成の複素環モジュレーター
KR20160100329A (ko) * 2013-12-20 2016-08-23 3-브이 바이오사이언시스, 인코포레이티드 지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
CA2935767C (en) * 2014-01-07 2023-01-31 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
ES2833454T3 (es) * 2014-08-15 2021-06-15 Sagimet Biosciences Inc Inhibidor de la ácido graso sintasa para su uso en el tratamiento de un cáncer farmacorresistente
CN107428728A (zh) * 2015-03-19 2017-12-01 3-V生物科学股份有限公司 脂质合成的杂环调节剂

Similar Documents

Publication Publication Date Title
JP2013544860A5 (enExample)
AR089134A1 (es) Arilos y heteroarilos biciclicos inhibidores de los canales de sodio
JP2017505291A5 (enExample)
JP2013545816A5 (enExample)
JP2016517417A5 (enExample)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2013545818A5 (enExample)
JP2013545817A5 (enExample)
JP2020530487A5 (enExample)
JP2010536887A5 (enExample)
JP2013537203A5 (enExample)
JP2014510727A5 (enExample)
JP2010031025A5 (enExample)
JP2008503591A5 (enExample)
JP2019518766A5 (enExample)
JP2013531029A5 (enExample)
RU2010114828A (ru) Производные урацила или тимина для лечения гепатита с
JP2012526728A5 (enExample)
JP2017504576A5 (enExample)
JP2010518128A5 (enExample)
JP2011509309A5 (enExample)
JP2014532716A5 (enExample)
JP2014520898A5 (enExample)
JP2010524932A5 (enExample)
JP2014506599A5 (enExample)